glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment Excessive glutathione intake contributes to
Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC GPX4 Inhibitor Resistance and Metastatic Features in TripleNegative Breast Cancer Sabatier 2026 Advanced Science Wiley Online Library NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



